Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABCD ScoreAdjusted Body WeightBody Mass IndexDiaRem ScoreIdeal Weight & Excess Weight Loss
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Body Mass Index

Body Mass Index (WHO Classification): Validated screening tool for weight categories and obesity assessment. In bariatric surgery, BMI ≥40 or ≥35 with comorbidities guides surgical candidacy. Updated 2024 guidelines recommend evaluation for patients ≥35 with obesity-related comorbidities like type 2 diabetes, hypertension, sleep apnea, or GERD.

cm
kg
Underweight0–18.5
Normal Weight18.5–25
Overweight25–30
Obesity Class I30–35
Obesity Class II35–40
Obesity Class III (Morbid)≥ 40

Awaiting Input

WHO classification for adults

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Primary Clinical Uses

Population-level metabolic screening and surveillance
Bariatric surgery candidacy (BMI ≥40 or ≥35 with comorbidity)
Eligibility screening for GLP-1 receptor agonists (semaglutide/liraglutide)
Monitoring progress in structured weight management programmes
Risk stratification for T2DM, hypertension, sleep apnoea, and CVD

When NOT to Use Alone

AMA 2023 policy explicitly recommends against using BMI as the sole criterion for clinical decision-making, particularly for bariatric surgery eligibility or pharmacotherapy access.

How it Works

Formula

BMI (metric) = Weight (kg) ÷ Height2 (m2) BMI (imperial) = 703 × Weight (lbs) ÷ Height2 (in2)

WHO Classification

Underweight< 18.5 kg/m2
Normal Weight18.5 – 24.9 kg/m2
Overweight25 – 29.9 kg/m2
Obesity Class I30 – 34.9 kg/m2
Obesity Class II35 – 39.9 kg/m2
Obesity Class III (Morbid)≥ 40 kg/m2

Historical Context

Quetelet's Index (1832) was repurposed as 'Body Mass Index' by Ancel Keys in 1972. It was never designed as a diagnostic tool for individuals — only as a population-level comparator among White, middle-aged European men.

Clinical Pearls

Key Advantages

Inexpensive, non-invasive, rapid — no specialist equipment beyond scales and stadiometer
Serial BMI trends over time are more informative than single snapshots
Strong population-level predictor of T2DM, CVD, and metabolic syndrome
Universal threshold for surgical eligibility and pharmacotherapy criteria

Known Limitations

Misclassifies muscular athletes as overweight (no fat-mass measurement)
Underestimates visceral adiposity risk in South Asians
Does not distinguish abdominal vs peripheral adiposity distribution
"Obesity paradox" in elderly: modest overweight (25–29.9) may be protective
Not validated standalone in children — use age/sex z-scores
Fitness level can mask BMI risk — the "fat but fit" phenomenon

Ethnicity-Adjusted Cut-offs

South Asian≥ 27.5 kg/m2 for obesity
Chinese (national guideline)≥ 28 kg/m2 for obesity
India (2015)≥ 25 kg/m2 = overweight
Elderly (> 65 yrs)25–30 may be acceptable

Next Steps

BMI ≥ 30 — Immediate Actions

01
Screen for comorbidities: T2DM, HTN, dyslipidaemia, OSA, NAFLD
02
Calculate Adjusted Body Weight for medication dosing
03
Assess EOSS (Edmonton Obesity Staging System) for intervention intensity
04
Consider GLP-1 receptor agonist therapy if no contraindications
05
Measure waist circumference + waist-to-hip ratio for CVD stratification

BMI ≥ 35 or ≥ 40 — Escalate to Bariatric Evaluation

01
Refer to multidisciplinary bariatric surgery team
02
Calculate ABCD Score for surgical T2DM remission prediction
03
Calculate DiaRem Score for diabetes remission probability
04
Document all obesity-related comorbidities for surgical candidacy documentation

Complementary Calculators

Adjusted Body Weight
ABCD Score
DiaRem Score

The Evidence

Foundational Reference

Indices of relative weight and obesity.

Keys A et al. • J Chronic Dis.. 1972;25(6):329-343. Formal naming of Body Mass Index.

Key Validation

Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity.

Wu Y et al. • Int J Environ Res Public Health.. 2024;21(6):757. 43,000+ views. Yale School of Public Health. Open access.

Guideline References

AMA adopts new policy clarifying role of BMI as a measure in medicine.

AMA Council on Science and Public Health. • AMA Press Release.. 2023;Recommends against BMI as sole diagnostic criterion.

Lancet Diabetes & Endocrinology Commission on Clinical Obesity.

Rubino F et al. • Lancet Diabetes Endocrinol.. 2023;11:226-228.

Origins & History

Adolphe Quetelet (1796–1874)

Belgian mathematician and statistician. Devised the weight/height2 index in the 1830s to compare body habitus among White, European men. He called it the 'Quetelet Index' — entirely a population statistic, never intended for individual clinical assessment.

Ancel Keys (1904–2004)

American physiologist famous for the Seven Countries Study. Renamed the Quetelet Index 'Body Mass Index' in 1972 after evaluating several anthropometric alternatives. Keys himself acknowledged its limitations at the individual patient level.

Modern Debate

BMI cut-offs have shifted multiple times since 1993 across WHO, NIH, and international bodies. The current thresholds were not derived from clinical trials but from epidemiological modelling — explaining the ongoing debate about universal applicability across ethnicities.

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

Emerging Infectious DiseasesJul 15, 2026
Occupationally Exposed and General Population Antibody Profiles to Influenza A Viruses Circulating in Swine as Indication of Zoonotic Risk

Clinical Context

We think this might be relevant to the clinical guidance for Body Mass Index (BMI).

Alzheimers & DementiaJul 15, 2026
Deep learning‐based MRI analysis reveals Lewy body co‐pathology accelerates brain aging in Alzheimer's disease

Clinical Context

We think this might be relevant to the clinical guidance for Body Mass Index (BMI).

Alzheimers & DementiaJul 15, 2026
Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus

Clinical Context

We think this might be relevant to the clinical guidance for Body Mass Index (BMI).